J B Chemicals & Pharmaceuticals Ltd Share Price (JBCHEPHARM)
Check the latest share price of J B Chemicals & Pharmaceuticals Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
J B Chemicals & Pharmaceuticals Ltd Stock Performance
Get live J B Chemicals & Pharmaceuticals Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹1,689Day's Price Range₹1,739.952 Week's Low
52 Week's High
₹1,385.7552-Week Price Range₹2,030
| Returns % | |
| 1 Month Return | + 7.55 % |
| 3 Month Return | + 13.94 % |
| 1 Year Return | -6.47 % |
| 3 Year Return | + 128.97 % |
| 5 Year Return | + 394.72 % |
| Market Stats | |
| Previous Close | ₹1,745.30 |
| Open | ₹1,730.00 |
| Volume | 1.48L |
| Upper Circuit | ₹2,094.30 |
| Lower Circuit | ₹1,396.30 |
J B Chemicals & Pharmaceuticals Ltd Fundamentals & Key Indicators
Check J B Chemicals & Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹27,052.05 Cr
Return on Equity (ROE)
20.39
PE Ratio (TTM)
40.86
Return on capital employed (ROCE)
24.83
Industry PE ratio
57.39
Beta (LTM)
0.53
P/B Ratio
8.87
Dividend Yield
0.74
PEG Ratio
3.62
Quarterly Earnings Growth YOY
15.48
EPS (TTM)
35.61
Sector
Pharmaceuticals
Book Value
188.36
Technical Analysis
Bullish
View Technical Analysis
How to invest in J B Chemicals & Pharmaceuticals Ltd?
Investing in J B Chemicals & Pharmaceuticals Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for J B Chemicals & Pharmaceuticals Ltd or JBCHEPHARM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of J B Chemicals & Pharmaceuticals Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like J B Chemicals & Pharmaceuticals Ltd with just a few clicks!
J B Chemicals & Pharmaceuticals Ltd Stock's Interest Amongst Investors
J B Chemicals & Pharmaceuticals Ltd Valuation
Track how J B Chemicals & Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
J B Chemicals & Pharmaceuticals Ltd in the last 5 years
Lowest (10.61x)
October 24, 2019
Today (40.86x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (62.92x)
February 7, 2024
Today’s Price to Earnings Ratio: 40.86x
J B Chemicals & Pharmaceuticals Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on J B Chemicals & Pharmaceuticals Ltd.
based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
92.31% of analysts recommend a 'BUY' rating for J B Chemicals & Pharmaceuticals Ltd. Average target price of ₹2048.77
Source: S&P Global Market Intelligence
J B Chemicals & Pharmaceuticals Ltd Share Price Target
Get share price movements and forecasts by analysts on J B Chemicals & Pharmaceuticals Ltd.
J B Chemicals & Pharmaceuticals Ltd price forecast by 13 analysts
Upside of18.13%
High
₹2457
Target
₹2048.77
Low
₹1595
J B Chemicals & Pharmaceuticals Ltd target price ₹2048.77, a slight upside of 18.13% compared to current price of ₹1734.4. According to 13 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
J B Chemicals & Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:40.34%
Forecast
Actual
Including amortisation and stock based compensations
J B Chemicals & Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:69.92%
Forecast
Actual
Source: S&P Global Market Intelligence
J B Chemicals & Pharmaceuticals Ltd Financial Results
Get the annual and quarterly financial summary of J B Chemicals & Pharmaceuticals Ltd, including revenue, profit, loss and more.
Indices Featuring J B Chemicals & Pharmaceuticals Ltd Stock
Check stock indices that include J B Chemicals & Pharmaceuticals Ltd.
J B Chemicals & Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of J B Chemicals & Pharmaceuticals Ltd.
J B Chemicals & Pharmaceuticals Ltd Earnings Results
J B Chemicals & Pharmaceuticals Ltd’s net profit jumped 15.48% since last year same period to ₹145.69Cr in the Q4 2024-2025. On a quarterly growth basis, J B Chemicals & Pharmaceuticals Ltd has generated -10.34% fall in its net profits since last 3-months.
Read More about Earnings ResultsJ B Chemicals & Pharmaceuticals Ltd Dividends February,2025
In the quarter ending December 2024, J B Chemicals & Pharmaceuticals Ltd has declared dividend of ₹8.50 - translating a dividend yield of 1.20%.
Read More about Dividends
J B Chemicals & Pharmaceuticals Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in J B Chemicals & Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 47.84% | 0.00 | |
| Foreign Institutions | 18.3% | 0.00 | |
| Mutual Funds | 16.26% | 0.00 | |
| Retail Investors | 15.14% | 0.00 | |
| Others | 2.45% | 0.00 |
J B Chemicals & Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of J B Chemicals & Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 27,052.05 | 78.94% | 0.56 | 552 | 3,484 | |
| BUY | 38,428.87 | 101.79% | 0.52 | 300 | 1,051 | |
| BUY | 17,430.61 | 17.42% | 0.57 | 72 | 6,702 | |
| NA | 5,383.81 | 2.8% | 0.79 | -388 | 75 | |
| BUY | 14,436.59 | 43.15% | 0.68 | 244 | 1,515 |
J B Chemicals & Pharmaceuticals Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in J B Chemicals & Pharmaceuticals Ltd.
J B Chemicals Allocates Shares Under ESOS - 05 Jun, 2025
J B Chemicals & Pharmaceuticals has allotted 112,990 equity shares under its Employee Stock Option Scheme, 2021, raising Rs. 5.16 crore. The company's paid-up capital increased accordingly.JB Pharma Remains Resilient Amid US Policy Changes - 17 May, 2025
JB Chemicals & Pharmaceuticals expects no impact from recent US policy changes on its lozenges-centric CDMO business, which constitutes 80% of its operations. The company reported a 12% revenue increase to ₹3,918 crore for FY25, with significant growth in operating EBITDA and profit after tax. JB Pharma continues to expand its presence globally, focusing on key markets outside the US.J.B. Chemicals & Pharmaceuticals Maintains Positive Outlook - 16 May, 2025
Prabhudas Lilladher maintains a BUY rating for J.B. Chemicals & Pharmaceuticals with a target price of Rs 2,030. The company shows strong growth potential driven by geographical expansion, improved productivity, and new product launches, with an expected EPS CAGR of 22% over FY25-27E.JB Chemicals Reports Strong Q4 FY25 Performance - 14 May, 2025
JB Chemicals & Pharmaceuticals announced a solid performance for Q4 FY25, with a 15.5% increase in net profit and 10.2% revenue growth. The company highlighted strong contributions from domestic formulations and CDMO segments, with an operating margin expansion. A final dividend of ₹7 per share was proposed, reflecting confidence in sustained growth.
Insights on J B Chemicals & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 14.64% to 18.30% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, JBCHEPHARM stock has moved up by 3.4%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 14.57% to 16.26% in Mar 2025 quarter
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 53.66% to 47.84% in Mar 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, 176.83 Cr → 145.69 Cr (in ₹), with an average decrease of 6.2% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 1.01K Cr → 963.96 Cr (in ₹), with an average decrease of 2.3% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 15.29% to 15.14% in Mar 2025 quarter
About J B Chemicals & Pharmaceuticals Ltd
Revenue: ₹949.48Cr as on March 2025 (Q4 FY25)
Net Profit: ₹145.69Cr as on March 2025 (Q4 FY25)
Listing date: 02 Feb, 1995
Chairperson Name: Ranjit Shahani.
| Organisation | J B Chemicals & Pharmaceuticals Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Ranjit Shahani. |
| E-voting on shares | Click here to vote |
Mutual Funds that own J B Chemicals & Pharmaceuticals Ltd
Check out the Mutual Funds with significant holdings in J B Chemicals & Pharmaceuticals Ltd.
FAQs
What is J B Chemicals & Pharmaceuticals Ltd share price today?
J B Chemicals & Pharmaceuticals Ltd share price today stands at ₹1734.4, Open: ₹1730, Previous Close: ₹1745.3, High: ₹1739.9, Low: ₹1689, 52 Week High: ₹2030, 52 Week Low: ₹1385.75.
What is today's traded volume of J B Chemicals & Pharmaceuticals Ltd?
Today's traded volume of J B Chemicals & Pharmaceuticals Ltd is 1.48L. Which means that 1.48L shares of J B Chemicals & Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
What is J B Chemicals & Pharmaceuticals Ltd's market cap today?
Today's market capitalisation of J B Chemicals & Pharmaceuticals Ltd is ₹27,052.05 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of J B Chemicals & Pharmaceuticals Ltd?
J B Chemicals & Pharmaceuticals Ltd’s 52 week high is ₹2030 and 52 week low is ₹1385.75. The current share price of J B Chemicals & Pharmaceuticals Ltd is ₹1734.4, which is -14.56% down from its 52 week high and 25.16% up from its 52 week low.